
Cancer guidelines need to fit the care people can actually access. This editorial calls for local evidence, affordable options and equity to shape recommendations from the start. @ishukataria3 @SullivanProf bmjoncology.bmj.com/content/…
✓Cancer, Conflict and Global Health

Cancer guidelines need to fit the care people can actually access. This editorial calls for local evidence, affordable options and equity to shape recommendations from the start. @ishukataria3 @SullivanProf bmjoncology.bmj.com/content/…

Further work on Syria and r4hsss.org program - stregthening cancer systems in post conflict Syria frontiersin.org/journals/can…

An engaging #ASCO26 session: A Workforce Crisis—A Lancet Oncology Commission Authors @hedvighricak, @QUBCancerProf, @SullivanProf, @sudhasdc, @m_mutebi, @Dra_CVillarreal, @WilNgwa + Missed the session? 📽️ Watch: youtu.be/VYr2Bjmxyhg & 📖 Read: thelancet.com/commissions-do…

A final word on GRAiL in JAMA - promise, hype and reality - academia.edu/167998188/Multi… @ASCO @myESMO

Addressing the “Intellectual Wastelands” of Global Cancer Policy - Richard Sullivan @SullivanProf oncodaily.com/voices/richard… #OncoDaily #Oncology #Cancer #Health #Medicine #MedX #MedTwitter

While civilian injuries in the the Middle East have been widely documented, little is known about civilian trauma pathways. Read our latest in @GlobalHealthBMJ with @GhassanAbuSitt1, @abdulsaterz, @SullivanProf, @gmbowsher, @thewarspace among others. gh.bmj.com/content/11/5/e021…

Complexities of rebuilding breast cancer care in post-conflict Syria. Critical lessons for the wider world. academia.edu/166153347/Rebui… @R4HSSS @r4hcmena @BreastDocUK @BCCare @SusanGKomen

Brilliant. And absolutely spot on. blogs.bmj.com/bmj/2015/12/11… @RCSEd @IGSS_InciSioN @QueensGlobalOnc

Quite simply, a brilliantly written review on Chinese Pharma - From 2015 to 2024, over 393 cancer medicines were approved worldwide, 72 were China's branded new medicines. eg; zanubrut, tisleliz, avaprit, toripali, fruquin. @SullivanProf @kjmeetswrld ascopubs.org/doi/10.1200/GO-…

What are the immediate and long-term implications of war for cancer care? Our editorial in @bmjoncology explores this question through lessons from Ukraine. With @gmbowsher, @SullivanProf, and Kateryna Denysenko: bmjoncology.bmj.com/content/…

Our new article about @WHO essential cancer medicines published today in JAMA Oncology with @SullivanProf We ask: how to implement these medicines? jamanetwork.com/journals/jam…

Final report from cancer conference organised by the Pontifical Academy of Sciences and the European Academy of Cancer Sciences, held in Vatican City in 2025 pubmed.ncbi.nlm.nih.gov/4139…

Disparity in affordability across targeted and Immune-therapy cancer medicines used in the treatment of Head and Neck cancer doi.org/10.1002/hed.70212

Huge gaps in our understanding of cancer care in refugee and asylum populations. academia.edu/164818349/Cance… @QF @WHO

New Correspondence in @TheLancet Cancer medicines remain absent from global access metrics. #accesstomedicines #globaloncology @SullivanProf @LSEHealthPolicy @KingsCollegeLon

Report from the Pontifical Academy of Sciences & European Academy of Cancer Sciences meeting held in Vatican City. A complex picture of innovation, global inequity & increasing divergence between science & systems implementation. pubmed.ncbi.nlm.nih.gov/4139… @WHO @EU_Commission